Prognostic role of chemotherapy-induced neutropenia in first-line treatment of advanced ovarian cancer. A pooled analysis of MITO2 and MITO7 trials

Giovanni Scambia, Maria Gabriella Ferrandina, Domenica Lorusso, Vanda Salutari, Gennaro Daniele, Laura Arenare, Carmela Pisano, Roberto Sorio, Enrico Breda, Sabino De Placido, Antonella Savarese, Francesco Raspagliesi, Pierluigi Benedetti Panici, Antonella Ferro, Anita Rimanti, Gennaro Cormio, Sabrina Chiara Cecere, Simona Scalone, Valentina Angela Marsico, Cinzia CardalesiFrancesco Cognetti, Laura Attademo, Lorenzo Guizzaro, Clorinda Schettino, Maria Carmela Piccirillo, Francesco Perrone, Ciro Gallo, Sandro Pignata

Risultato della ricerca: Contributo in rivistaArticolo in rivista

3 Citazioni (Scopus)

Abstract

Background: Chemotherapy-induced neutropenia (CIN) has been associated with improved prognosis in several cancer conditions. Contrasting data have been produced in ovarian cancer.
Lingua originaleEnglish
pagine (da-a)83-88
RivistaGynecologic Oncology
Volume154
DOI
Stato di pubblicazionePubblicato - 2019

Keywords

  • Chemotherapy-induced neutropenia
  • Cytotoxic dosing methods
  • Meta-analysis
  • Obstetrics and Gynecology
  • Oncology
  • Ovarian cancer
  • Prognostic factors
  • Retrospective-prospective design

Fingerprint Entra nei temi di ricerca di 'Prognostic role of chemotherapy-induced neutropenia in first-line treatment of advanced ovarian cancer. A pooled analysis of MITO2 and MITO7 trials'. Insieme formano una fingerprint unica.

Cita questo